WolverHeme Happy Hour

Episode 49.5: R-CHOP and Chill - the Coolest Therapies at the Front of our Minds

In this episode, Bernie and Anthony team up with lymphoma experts Dr. Jon Weiss, Dr. James Davis, Dr. Eugene Przespolewski, and Dr. Aaron "Papa Heme" Goodman to discuss t

VAR Review with Dr. Bixby: Reversing the Call on MPAL

In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous

Bispecifics ate CAR-T's lunch: a multiple myeloma debate

In this episode, Bernie and Anthony are joined by Myeloma Man Manni Mohyuddin, MD to discuss the debate surrounding the treatment of first relapse in multiple myeloma. Sh

Episode 47: Cult-Like Thinking in BMT

“However much we flatter ourselves about our individual rationality, a good story, no matter how analytically deficient, lingers in the mind, resonates emotionally, and p

Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology

In this special video episode, Bernie and Anthony moderate a Common Sense Oncology discussion of key trials from ASH 2025! We are joined by special guest experts from acr

HLH: From Chaos to Clarity... and Back to Chaos!

In this episode, Anthony and Bernie are joined by a panel of experts to discuss (and debate) everyone's favorite (or most feared) hematology topic - hemophagocytic lympho

An Exercise in Uncertainty with Jonathan Gluck

Anthony and Bernie are joined by special guest Jonathan Gluck, award-winning journalist and author of "An Exercise in Uncertainty: A Memoir of Illness and Hope" for a pow

ASH Leukemia Review: the more we learn, the less we know!

In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in le

RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy

Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice.  https://meetings-api

MajesTEC-3 and ASH 2025: Let's get "TEC"nical

In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3

Episode 40: Coffee and Community Hematology

In this episode, Anthony and Bernie discuss the important role of community hematology. We discuss innovative research models, partnerships between community and academic

Chill For 5: The Febrile Neutropenia Survival Guide

In this episode, Bernie and Anthony review the optimal management of febrile neutropenia! We talk about some historical data, optimal patient workup, proper selection of

Episode 38: Prophy and Pints!

We're back after a summer break! In this episode, Anthony and Bernie review the optimal approach to antimicrobial prophylaxis in hematology patients. How do you best choo

Episode 37: Spilling Drinks over Cytarabine Dosing

In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your

Episode 36: ODAC - Our Decisions Are Confusing

In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisi

CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined

This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinic

Dex and the Cytokine City: Managing CRS with Bispecifics

In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP -

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Shoul

Episode 32: Navigating a BlinatumoMAD World

In this episode, Anthony and Bernie are joined by two special guests to discuss recent updates to the use of blinatumomab in both adult and pediatric acute lymphoblastic

The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma

AQUILA is a constellation shaped like an eagle, and also a hotly debated myeloma trial of daratumumab in smoldering multiple myeloma. In this episode, Bernie and Anthony